Twine Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Teiko Bioteiko.bioin𝕏Sep 2021
Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.
BiotechDigital HealthHealthtechSalt Lake City, US
Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)
BoardVictor Wang(Director)in
Co-investorsCivilization Ventures Management, LlcHAWKTAILHOF CapitalTau VenturesWestern Technology Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.